On March 15, 2018 prof Joachim Aerts MD of Erasmus MC received a “Parel” (Pearl) from ZonMW for his research on dendritic cell immunotherapy MesoPher for mesothelioma. ZonMW is the The Netherlands Organisation for Health Research and Development.

The Dutch patient association, Asbestslachtoffers Vereniging Nederland (AVN) and Amphera received an “Oorkonde” (certificate) for their contributions to this study.

Amphera truly appreciates the Oorkonde, as it is an acknowledgement of the productive collaboration between an academic hospital, a patient association and a small biotech company.

More information (in Dutch) can be found on: https://www.zonmw.nl/nl/actueel/nieuws/detail/item/zonmw-parel-voor-afweerreactie-tegen-asbestkanker